RESMED INC 8-K

What Happened

• ResMed Inc. (RMD) filed a Current Report on Form 8-K on January 29, 2026 (Item 2.02 and Item 8.01) furnishing a press release (Exhibit 99.1) that describes the company’s results of operations for the quarter ended December 31, 2025.
• On the same date the board declared a quarterly cash dividend of US $0.60 per share.

Key Details

• Press release furnished as Exhibit 99.1 on January 29, 2026, reporting results for the quarter ended December 31, 2025.
• Dividend: US $0.60 per share; record date February 12, 2026; payable March 19, 2026.
• Ex-dividend date: February 11, 2026 (applies to both NYSE common stock and ASX CHESS Depositary Instruments).
• CDI holders on the Australian Securities Exchange will receive the equivalent amount in Australian dollars based on the exchange rate on the record date, reflecting the 10:1 ratio between CDIs and NYSE shares; ResMed obtained an ASX waiver to defer processing conversions between its common stock and CDI registers from Feb 11–12, 2026 (inclusive).

Why It Matters

• The filing provides the company’s quarterly results (earnings/revenue and related operational info) via the furnished press release — important for investors assessing recent performance.
• The $0.60/share dividend is a concrete cash return and sets the timeline (ex-dividend, record, and payment dates) for investors who must hold shares by the record date to be eligible.
• CDI holders should note currency conversion and the 10:1 ratio, and the ASX waiver that temporarily alters conversion processing around the ex-dividend/record dates.